NO20004822L - Oral active substance suspension - Google Patents

Oral active substance suspension

Info

Publication number
NO20004822L
NO20004822L NO20004822A NO20004822A NO20004822L NO 20004822 L NO20004822 L NO 20004822L NO 20004822 A NO20004822 A NO 20004822A NO 20004822 A NO20004822 A NO 20004822A NO 20004822 L NO20004822 L NO 20004822L
Authority
NO
Norway
Prior art keywords
active substance
substance suspension
oral active
oral
suspension
Prior art date
Application number
NO20004822A
Other languages
Norwegian (no)
Other versions
NO321401B1 (en
NO20004822D0 (en
Inventor
Dietrich Tuerck
Veit Schmelmer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20004822D0 publication Critical patent/NO20004822D0/en
Publication of NO20004822L publication Critical patent/NO20004822L/en
Publication of NO321401B1 publication Critical patent/NO321401B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
NO20004822A 1998-03-27 2000-09-26 Pharmaceutical composition for oral administration and method of preparation thereof NO321401B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98105568A EP0945131A1 (en) 1998-03-27 1998-03-27 Peroral drug suspension
PCT/EP1999/001948 WO1999049845A1 (en) 1998-03-27 1999-03-23 Peroral active agent suspension

Publications (3)

Publication Number Publication Date
NO20004822D0 NO20004822D0 (en) 2000-09-26
NO20004822L true NO20004822L (en) 2000-11-23
NO321401B1 NO321401B1 (en) 2006-05-08

Family

ID=8231651

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004822A NO321401B1 (en) 1998-03-27 2000-09-26 Pharmaceutical composition for oral administration and method of preparation thereof

Country Status (26)

Country Link
EP (2) EP0945131A1 (en)
JP (1) JP3323189B2 (en)
KR (1) KR100587208B1 (en)
CN (1) CN1150888C (en)
AR (1) AR016196A1 (en)
AT (1) ATE225648T1 (en)
AU (1) AU762464B2 (en)
BR (1) BR9909189A (en)
CA (1) CA2326048C (en)
CO (1) CO5070601A1 (en)
DE (1) DE59903023D1 (en)
DK (1) DK1066029T3 (en)
ES (1) ES2184428T3 (en)
HK (1) HK1034184A1 (en)
HU (1) HU228474B1 (en)
IL (1) IL137479A (en)
MY (1) MY124599A (en)
NO (1) NO321401B1 (en)
NZ (1) NZ507610A (en)
PL (1) PL192969B1 (en)
PT (1) PT1066029E (en)
TR (1) TR200002772T2 (en)
TW (1) TWI232759B (en)
UY (1) UY25443A1 (en)
WO (1) WO1999049845A1 (en)
ZA (1) ZA200003951B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8231899B2 (en) 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (en) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Highly concentrated stable meloxicam solutions for needleless injection
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20100297252A1 (en) 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
US8512727B2 (en) * 2003-03-03 2013-08-20 Alkermes Pharma Ireland Limited Nanoparticulate meloxicam formulations
EP1938803A3 (en) * 2003-03-03 2010-10-27 Elan Pharma International Limited Formulations comprising nanoparticulate meloxican
US20070042006A1 (en) * 2003-04-07 2007-02-22 Lau Kai K Stable carprofen composition
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
WO2006042381A1 (en) * 2004-10-21 2006-04-27 Parnell Laboratories (Aust) Pty Limited Anti-inflammatory preparation
DE602005009016D1 (en) * 2004-12-06 2008-09-25 Janssen Pharmaceutica Nv ORAL SUSPENSION WITH MELOXICAM
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
CA2777366C (en) * 2009-10-12 2023-11-14 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
CA2800235C (en) * 2010-03-10 2018-10-16 Lupin Limited Rifaximin ready-to-use suspension
RU2015142279A (en) * 2010-03-19 2018-12-28 Бостон Байомедикал, Инк. NEW COMPOUNDS AND COMPOSITIONS FOR TARGETING MALIGNANT STEM CELLS
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
GB201117858D0 (en) 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
CN104854411B (en) * 2012-12-19 2017-06-13 三菱电机株式会社 Air conditioner
RU2749423C2 (en) 2015-04-28 2021-06-10 Марс, Инкорпорейтед Method for producing sterilized wet feed product for pets
KR102145022B1 (en) * 2018-08-14 2020-08-14 동아제약 주식회사 Suspension composition and dosage form of ibuprofen
CN112044605B (en) * 2019-06-06 2022-06-21 钟志勇 Titanium selection medicament and titanium selection method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196307B (en) * 1984-10-22 1988-11-16 Chiesi Farma Spa AQUEOUS PHARMACEUTICAL FORMULATIONS OF PIROXICAM MONOHYDRATE
US4835187A (en) * 1987-06-15 1989-05-30 American Home Products Corporation Spray dried ibuprofen
JP2860729B2 (en) * 1992-03-10 1999-02-24 エスエス製薬株式会社 Planoprofen suspension syrup
GB2318511A (en) * 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water

Also Published As

Publication number Publication date
EP1066029B1 (en) 2002-10-09
JP3323189B2 (en) 2002-09-09
MY124599A (en) 2006-06-30
DK1066029T3 (en) 2003-01-27
KR100587208B1 (en) 2006-06-08
AU3147099A (en) 1999-10-18
JP2002509875A (en) 2002-04-02
CN1295462A (en) 2001-05-16
PL192969B1 (en) 2006-12-29
WO1999049845A1 (en) 1999-10-07
HUP0102036A2 (en) 2002-03-28
TR200002772T2 (en) 2000-12-21
HU228474B1 (en) 2013-03-28
PL342345A1 (en) 2001-06-04
TWI232759B (en) 2005-05-21
NO321401B1 (en) 2006-05-08
ES2184428T3 (en) 2003-04-01
KR20010042197A (en) 2001-05-25
BR9909189A (en) 2000-12-05
HUP0102036A3 (en) 2002-12-28
CA2326048C (en) 2008-08-12
AR016196A1 (en) 2001-06-20
AU762464B2 (en) 2003-06-26
ZA200003951B (en) 2002-01-18
IL137479A0 (en) 2001-07-24
IL137479A (en) 2005-09-25
DE59903023D1 (en) 2002-11-14
NO20004822D0 (en) 2000-09-26
ATE225648T1 (en) 2002-10-15
CO5070601A1 (en) 2001-08-28
HK1034184A1 (en) 2001-10-19
PT1066029E (en) 2003-02-28
CN1150888C (en) 2004-05-26
EP1066029A1 (en) 2001-01-10
CA2326048A1 (en) 1999-10-07
NZ507610A (en) 2003-08-29
EP0945131A1 (en) 1999-09-29
UY25443A1 (en) 1999-11-17

Similar Documents

Publication Publication Date Title
NO20004822D0 (en) Oral active substance suspension
DE69834425D1 (en) SUPPORTED IMPLANT
DE69920227D1 (en) FLUORED ELECTRET
FR2780269B1 (en) RACHIDIAN IMPLANT
IS5568A (en) Pharmacologically active morpholinol
DE59909242D1 (en) REFERENCE ELECTRODE
DE60000003T2 (en) paroxetine
DE29819892U1 (en) Ear prosthesis
DE60008009D1 (en) SINGLE SUSPENSION
DK1300129T3 (en) Implant vial
DE60007530D1 (en) ORAL EFFECTIVE ANDROGENE
DE59913860D1 (en) MIDDLE EAR IMPLANT
DE69928344D1 (en) Pharmaceutical implant
DE69903524D1 (en) PESTICIDIC AIDS
DE69818638D1 (en) DENTAL IMPLANT
NO20002590D0 (en) Formulations comprising dissolved paroxetine
ATA40797A (en) IMPLANT
NO20005769D0 (en) cyclosporin derivatives
DE69934741D1 (en) suspension
DE29709725U1 (en) Implant
NO20005683D0 (en) New formulation containing paroxetine
ATA65598A (en) DENTAL IMPLANT
ID23006A (en) 13-DIHIDRO-3 'AZIRIDINO ANTRASIKLINA
DE29817687U1 (en) Envelope
KR980003246U (en) Removable capsule toilet

Legal Events

Date Code Title Description
MK1K Patent expired